Ani Pharmaceuticals (ANIP) Assets Growth (1y) (2011 - 2026)
Powered by 
Analysis
Ani Pharmaceuticals (ANIP) Assets Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.53 Bn | 38.88 Bn | 2.15 Bn |
| 2 | Viatris | 19.14 Bn | 18.25 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.45 Bn | 5.33 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.33 Bn | 492.63 Mn | 2.10 Bn |
| 6 | Alvotech | 1.51 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.48 Bn | 1.12 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 992.90 Mn | 702.78 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 400.20 Mn | 358.95 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 178.79 Mn | 178.79 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.25% |
| Mar 31, 2026 | 10.02% |
| Dec 31, 2025 | 12.14% |
| Sep 30, 2025 | 9.38% |
| Jun 30, 2025 | 45.86% |
| Mar 31, 2025 | 41.32% |
| Dec 31, 2024 | 42.02% |
| Sep 30, 2024 | 44.66% |
| Jun 30, 2024 | 7.15% |
| Mar 31, 2024 | 19.51% |
| Dec 31, 2023 | 18.99% |
| Sep 30, 2023 | 20.40% |
| Jun 30, 2023 | 14.38% |
| Mar 31, 2023 | 2.74% |
| Dec 31, 2022 | -1.49% |
| Sep 30, 2022 | 57.11% |
| Jun 30, 2022 | 56.48% |
| Mar 31, 2022 | 60.58% |
| Dec 31, 2021 | 67.31% |
| Sep 30, 2021 | 1.70% |